242 related articles for article (PubMed ID: 29188511)
1. AAV Gene Augmentation Therapy for CRB1-Associated Retinitis Pigmentosa.
Alves CH; Wijnholds J
Methods Mol Biol; 2018; 1715():135-151. PubMed ID: 29188511
[TBL] [Abstract][Full Text] [Related]
2. Loss of CRB2 in Müller glial cells modifies a CRB1-associated retinitis pigmentosa phenotype into a Leber congenital amaurosis phenotype.
Quinn PM; Mulder AA; Henrique Alves C; Desrosiers M; de Vries SI; Klooster J; Dalkara D; Koster AJ; Jost CR; Wijnholds J
Hum Mol Genet; 2019 Jan; 28(1):105-123. PubMed ID: 30239717
[TBL] [Abstract][Full Text] [Related]
3. Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in
Boon N; Alves CH; Mulder AA; Andriessen CA; Buck TM; Quinn PMJ; Vos RM; Koster AJ; Jost CR; Wijnholds J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808129
[TBL] [Abstract][Full Text] [Related]
4. Loss of CRB2 in the mouse retina mimics human retinitis pigmentosa due to mutations in the CRB1 gene.
Alves CH; Sanz AS; Park B; Pellissier LP; Tanimoto N; Beck SC; Huber G; Murtaza M; Richard F; Sridevi Gurubaran I; Garcia Garrido M; Levelt CN; Rashbass P; Le Bivic A; Seeliger MW; Wijnholds J
Hum Mol Genet; 2013 Jan; 22(1):35-50. PubMed ID: 23001562
[TBL] [Abstract][Full Text] [Related]
5. CRB2 acts as a modifying factor of CRB1-related retinal dystrophies in mice.
Pellissier LP; Lundvig DM; Tanimoto N; Klooster J; Vos RM; Richard F; Sothilingam V; Garcia Garrido M; Le Bivic A; Seeliger MW; Wijnholds J
Hum Mol Genet; 2014 Jul; 23(14):3759-71. PubMed ID: 24565864
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
[TBL] [Abstract][Full Text] [Related]
7. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS
Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotype.
Boon N; Lu X; Andriessen CA; Moustakas I; Buck TM; Freund C; Arendzen CH; Böhringer S; Mei H; Wijnholds J
Stem Cell Reports; 2023 May; 18(5):1123-1137. PubMed ID: 37084726
[TBL] [Abstract][Full Text] [Related]
9. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa.
Petersen-Jones SM; Occelli LM; Biel M; Michalakis S
Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Crumbs homolog 2 (CRB2) gene and analysis of its role in retinitis pigmentosa and Leber congenital amaurosis.
van den Hurk JA; Rashbass P; Roepman R; Davis J; Voesenek KE; Arends ML; Zonneveld MN; van Roekel MH; Cameron K; Rohrschneider K; Heckenlively JR; Koenekoop RK; Hoyng CB; Cremers FP; den Hollander AI
Mol Vis; 2005 Apr; 11():263-73. PubMed ID: 15851977
[TBL] [Abstract][Full Text] [Related]
11. Identification of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis pigmentosa.
Booij JC; Florijn RJ; ten Brink JB; Loves W; Meire F; van Schooneveld MJ; de Jong PT; Bergen AA
J Med Genet; 2005 Nov; 42(11):e67. PubMed ID: 16272259
[TBL] [Abstract][Full Text] [Related]
12. Human CRB1 and CRB2 form homo- and heteromeric protein complexes in the retina.
Stehle IF; Imventarza JA; Woerz F; Hoffmann F; Boldt K; Beyer T; Quinn PM; Ueffing M
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38570189
[No Abstract] [Full Text] [Related]
13. Genotypic and Phenotypic Characteristics of CRB1-Associated Retinal Dystrophies: A Long-Term Follow-up Study.
Talib M; van Schooneveld MJ; van Genderen MM; Wijnholds J; Florijn RJ; Ten Brink JB; Schalij-Delfos NE; Dagnelie G; Cremers FPM; Wolterbeek R; Fiocco M; Thiadens AA; Hoyng CB; Klaver CC; Bergen AA; Boon CJF
Ophthalmology; 2017 Jun; 124(6):884-895. PubMed ID: 28341475
[TBL] [Abstract][Full Text] [Related]
14. A case of CRB1-negative Coats-like retinitis pigmentosa.
Sarao V; Veritti D; Prosperi R; Pignatto S; Lanzetta P
J AAPOS; 2013 Aug; 17(4):414-6. PubMed ID: 23871396
[TBL] [Abstract][Full Text] [Related]
15. CRB2 Loss in Rod Photoreceptors Is Associated with Progressive Loss of Retinal Contrast Sensitivity.
Alves CH; Boon N; Mulder AA; Koster AJ; Jost CR; Wijnholds J
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438467
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy into photoreceptors and Müller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models.
Pellissier LP; Quinn PM; Alves CH; Vos RM; Klooster J; Flannery JG; Heimel JA; Wijnholds J
Hum Mol Genet; 2015 Jun; 24(11):3104-18. PubMed ID: 25701872
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
[TBL] [Abstract][Full Text] [Related]
18. Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa.
Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2018; 1715():33-46. PubMed ID: 29188504
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
[TBL] [Abstract][Full Text] [Related]
20. Course of Ocular Function in PRPF31 Retinitis Pigmentosa.
Hafler BP; Comander J; Weigel DiFranco C; Place EM; Pierce EA
Semin Ophthalmol; 2016; 31(1-2):49-52. PubMed ID: 26959129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
